BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24647400)

  • 1. Combined use of inactivated and oral poliovirus vaccines in refugee camps and surrounding communities - Kenya, December 2013.
    Sheikh MA; Makokha F; Hussein AM; Mohamed G; Mach O; Humayun K; Okiror S; Abrar L; Nasibov O; Burton J; Unshur A; Wannemuehler K; Estivariz CF;
    MMWR Morb Mortal Wkly Rep; 2014 Mar; 63(11):237-41. PubMed ID: 24647400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of wild polio virus outbreak investigation and response in Ethiopia in 2013-2014: implications for prevention of outbreaks due to importations.
    Tegegne AA; Braka F; Shebeshi ME; Aregay AK; Beyene B; Mersha AM; Ademe M; Muhyadin A; Jima D; Wyessa AB
    BMC Infect Dis; 2018 Jan; 18(1):9. PubMed ID: 29304745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.
    Ciapponi A; Bardach A; Rey Ares L; Glujovsky D; Cafferata ML; Cesaroni S; Bhatti A
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011260. PubMed ID: 31801180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the spread of polio in an IPV-vaccinated population: lessons learned from the 2013 silent outbreak in southern Israel.
    Yaari R; Kaliner E; Grotto I; Katriel G; Moran-Gilad J; Sofer D; Mendelson E; Miller E; Huppert A; ; Anis E; Kopel E; Manor Y; Mor O; Shulman L; Singer R; Weil M
    BMC Med; 2016 Jun; 14(1):95. PubMed ID: 27334457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress toward poliomyelitis eradication--Chad, January 2011-August 2012.
    Centers for Disease Control and Prevention
    MMWR Morb Mortal Wkly Rep; 2012 Oct; 61(42):858-62. PubMed ID: 23095955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined use of inactivated and oral poliovirus vaccines in a large-scale campaign in refugee camps and host communities – Kenya, December 2013.
    Wkly Epidemiol Rec; 2014 Mar; 89(12):127-32. PubMed ID: 24707518
    [No Abstract]   [Full Text] [Related]  

  • 8. Insights From Modeling Preventive Supplemental Immunization Activities as a Strategy to Eliminate Wild Poliovirus Transmission in Pakistan and Afghanistan.
    Kalkowska DA; Thompson KM
    Risk Anal; 2021 Feb; 41(2):266-272. PubMed ID: 32144841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States.
    Sutter RW; Prevots DR; Cochi SL
    Pediatr Clin North Am; 2000 Apr; 47(2):287-308. PubMed ID: 10761505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent Transmission of Circulating Vaccine-Derived Poliovirus - Somalia, January 2017-March 2024.
    Mendes A; Mohamed GA; Derow M; Stehling-Ariza T; Mohamed A; Mengistu K; Bullard K; Akbar IE; Shukla H; Al Safadi M; Martinez M
    MMWR Morb Mortal Wkly Rep; 2024 Jun; 73(25):575-580. PubMed ID: 38935565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine - Worldwide, 2016.
    Hampton LM; Farrell M; Ramirez-Gonzalez A; Menning L; Shendale S; Lewis I; Rubin J; Garon J; Harris J; Hyde T; Wassilak S; Patel M; Nandy R; Chang-Blanc D;
    MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(35):934-8. PubMed ID: 27606675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress toward interruption of wild poliovirus transmission--worldwide, January 2010-March 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 May; 60(18):582-6. PubMed ID: 21566559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Proactive and Reactive Strategies for Polio Eradication Activities in Pakistan and Afghanistan.
    Duintjer Tebbens RJ; Thompson KM
    Risk Anal; 2019 Feb; 39(2):389-401. PubMed ID: 30239026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in Africa.
    Cooper LV; Bandyopadhyay AS; Gumede N; Mach O; Mkanda P; Ndoutabé M; Okiror SO; Ramirez-Gonzalez A; Touray K; Wanyoike S; Grassly NC; Blake IM
    Lancet Infect Dis; 2022 Feb; 22(2):284-294. PubMed ID: 34648733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress toward interruption of wild poliovirus transmission--worldwide, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Apr; 58(12):308-12. PubMed ID: 19343011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress toward poliomyelitis eradication--Nigeria, 2005-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(12):278-81. PubMed ID: 17392680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.
    Li R; Li CG; Li Y; Liu Y; Zhao H; Chen X; Kuriyakose S; Van Der Meeren O; Hardt K; Hezareh M; Roy-Ghanta S
    Vaccine; 2016 Mar; 34(12):1436-43. PubMed ID: 26873055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community engagement and integrated health and polio immunisation campaigns in conflict-affected areas of Pakistan: a cluster randomised controlled trial.
    Habib MA; Soofi S; Cousens S; Anwar S; Haque NU; Ahmed I; Ali N; Tahir R; Bhutta ZA
    Lancet Glob Health; 2017 Jun; 5(6):e593-e603. PubMed ID: 28495264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction of Inactivated Poliovirus Vaccine and Switch from Trivalent to Bivalent Oral Poliovirus Vaccine - Worldwide, 2013-2016.
    Immunization Systems Management Group of the Global Polio Eradication Initiative
    MMWR Morb Mortal Wkly Rep; 2015 Jul; 64(25):699-702. PubMed ID: 26135591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the stability of polio eradication after the withdrawal of oral polio vaccine.
    Famulare M; Selinger C; McCarthy KA; Eckhoff PA; Chabot-Couture G
    PLoS Biol; 2018 Apr; 16(4):e2002468. PubMed ID: 29702638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.